Asset
Aldastotug
Pyxis Oncology Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05718557 | phase1 | active_not_recruiting | 2023-05-23 | 2026-05-01 | Pyxis Oncology, Inc | Study of PYX-106 in Solid Tumors |
FDA applications (0)
This company has no applications containing this asset.